moxifloxacin-placebo

DRUG2 trials

Sponsors

Peking University Third Hospital, AstraZeneca

Conditions

Non-alcoholic SteatohepatitisQT Interval Prolongation

Phase 1

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

TerminatedNCT05668936

AstraZenecaNon-alcoholic Steatohepatitis

Start: 2023-01-03End: 2023-03-10Updated: 2023-04-05

Unknown Phase

Moxifloxacin_QT Study in Chinese Healthy Volunteer

Peking University Third HospitalQT Interval Prolongation

Start: 2012-07-31End: 2012-10-31Target: 36Updated: 2012-07-31